Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Machine Learning in Nuclear Medicine: Part 1-Introduction.
Uribe CF, Mathotaarachchi S, Gaudet V, Smith KC, Rosa-Neto P, Bénard F, Black SE, Zukotynski K. Uribe CF, et al. Among authors: zukotynski k. J Nucl Med. 2019 Apr;60(4):451-458. doi: 10.2967/jnumed.118.223495. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733322 Free article. Review.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
Jani AB, Ravizzini GC, Gartrell BA, Siegel BA, Twardowski P, Saltzstein D, Fleming MT, Chau A, Davis P, Chapin BF, Schuster DM; SPOTLIGHT Study Group. Jani AB, et al. J Urol. 2023 Aug;210(2):299-311. doi: 10.1097/JU.0000000000003493. Epub 2023 Apr 26. J Urol. 2023. PMID: 37126069
The Global Reading Room: Performing a Gastric Emptying Study.
Bhambhvani P, Scarsbrook A, Van der Wall H, Zukotynski K. Bhambhvani P, et al. Among authors: zukotynski k. AJR Am J Roentgenol. 2023 Jul;221(1):139-140. doi: 10.2214/AJR.22.28657. Epub 2022 Oct 26. AJR Am J Roentgenol. 2023. PMID: 36287623 No abstract available.
Nuclear medicine in the first year of life.
Treves ST, Baker A, Fahey FH, Cao X, Davis RT, Drubach LA, Grant FD, Zukotynski K. Treves ST, et al. Among authors: zukotynski k. J Nucl Med. 2011 Jun;52(6):905-25. doi: 10.2967/jnumed.110.084202. J Nucl Med. 2011. PMID: 21622894 Free article. Review.
Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
Fahey F, Zukotynski K, Jadvar H, Capala J; organizing committee, contributors, and participants of the second NCI–SNMMI Workshop on Targeted Radionuclide Therapy. Fahey F, et al. Among authors: zukotynski k. J Nucl Med. 2015 Jul;56(7):1119-29. doi: 10.2967/jnumed.115.159038. Epub 2015 May 21. J Nucl Med. 2015. PMID: 25999432 Free article. No abstract available.
Diagnosing dementia.
Wang DC, Black SE, Zukotynski KA. Wang DC, et al. CMAJ. 2016 May 17;188(8):603. doi: 10.1503/cmaj.150508. Epub 2016 Apr 11. CMAJ. 2016. PMID: 27067820 Free PMC article. No abstract available.
Response Assessment Criteria and Their Applications in Lymphoma: Part 1.
Moghbel MC, Kostakoglu L, Zukotynski K, Chen DL, Nadel H, Niederkohr R, Mittra E. Moghbel MC, et al. Among authors: zukotynski k. J Nucl Med. 2016 Jun;57(6):928-35. doi: 10.2967/jnumed.115.166280. Epub 2016 Apr 28. J Nucl Med. 2016. PMID: 27127227 Free article. Review.
129 results